An adolescent is newly diagnosed with pediatric Crohn's disease and is being assessed for risk stratification before induction therapy. The treating team wants to align management with the updated ECCO-ESPGHAN guideline abstract.
What does the evidence in this abstract support for management of pediatric Crohn's disease?